会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT
    • 用于提取血液治疗的装置
    • US20170065760A1
    • 2017-03-09
    • US15353883
    • 2016-11-17
    • GAMBRO LUNDIA AB
    • Mauro SuffrittiMichela Carpani
    • A61M1/34B01D61/32B01D61/22
    • A61M1/341A61M1/1603A61M1/1615A61M1/3434A61M1/3437A61M1/3441A61M1/3639A61M2205/3331A61M2205/502A61M2205/52B01D61/22B01D61/32B01D2311/14
    • An apparatus for extracorporeal blood treatment, comprising a treatment unit (2) having a first chamber (3) and a second chamber (4) separated from one another by a semipermeable membrane (5), a blood removal line (6) connected in inlet with the first chamber (3) and a blood return line (7) connected in outlet with the first chamber; an infusion line (9; 9a, 9b) of a replacement fluid and a fluid evacuation line (10) connected in outlet from the second chamber. A regulating device (20) of a transmembrane pressure is active on at least one of the lines and a control unit (15) is configured to: command the regulating device (20) by setting a first increase (δTMP1), determine a value of a control parameter (φ1) corresponding to the first increase, compare the value of the control parameter (φ1) with a reference value (φref) and, if the value of the control parameter is greater than the reference value, command the regulating device (20) by setting a second increase (δTMP2) which is greater than the first increase (δTMP1).
    • 一种用于体外血液处理的装置,包括具有通过半透膜(5)彼此分离的第一室(3)和第二室(4)的处理单元(2),连接在入口 与第一腔室(3)和血液回流管线(7)连接在出口与第一腔室; 更换流体的输液管线(9; 9a,9b)和连接在第二室的出口处的排液管线(10)。 跨膜压力的调节装置(20)在至少一条线路上有效,并且控制单元(15)被配置为:通过设定第一增加(δTMP1)来指示调节装置(20),确定 对应于第一增加的控制参数(φ1),将控制参数(φ1)的值与参考值(φref)进行比较,并且如果控制参数的值大于参考值,则命令调节装置 20)通过设定大于第一增加(δTMP1)的第二增加(δTMP2)。